These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14049774)

  • 21. TUBE DILUTION SUSCEPTIBILITY RESPONSE OF CLINICALLY ISOLATED STAPHYLOCOCCI FROM SEVERAL COUNTRIES TO THREE PENICILLINS AND TRIACETYLOLEANDOMYCIN.
    ISENBERG HD
    Antimicrob Agents Chemother (Bethesda); 1964; 10():377-83. PubMed ID: 14287961
    [No Abstract]   [Full Text] [Related]  

  • 22. The incidence of corticosteroid side effects in chronic steroid-dependent asthmatics on TAO (troleandomycin) and methylprednisolone.
    Harris R; German D
    Ann Allergy; 1989 Aug; 63(2):110-1. PubMed ID: 2788376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIACETYLOLEANDOMYCIN.
    JERVEY L
    J S C Med Assoc (Columbia); 1964 May; 60():154-5. PubMed ID: 14145945
    [No Abstract]   [Full Text] [Related]  

  • 24. Triacetyloleandomycin in the treatment of severe infections in infants and children.
    OZYAZICI A; COHEN HJ; PRIGOT A
    Q Rev Pediatr; 1960; 15():102-9. PubMed ID: 14429613
    [No Abstract]   [Full Text] [Related]  

  • 25. [Triacetyloleandomycin (P.A. 777)].
    WAREMBOURG H; DESMET G; LEKIEFFRE J
    Lille Med; 1961 Mar; 6():238-43. PubMed ID: 13783140
    [No Abstract]   [Full Text] [Related]  

  • 26. Effectiveness of triacetyloleandomycin: in vitro and in vivo studies.
    WERTHAMER S; PECORA CL
    Antibiotic Med Clin Ther (New York); 1960 Sep; 7():560-5. PubMed ID: 13844064
    [No Abstract]   [Full Text] [Related]  

  • 27. A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids.
    Nelson HS; Hamilos DL; Corsello PR; Levesque NV; Buchmeier AD; Bucher BL
    Am Rev Respir Dis; 1993 Feb; 147(2):398-404. PubMed ID: 8430965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acne vulgaris treated with triacetyloleandomycin.
    PARKER W
    Med Times; 1962 Mar; 90():310-2. PubMed ID: 14483935
    [No Abstract]   [Full Text] [Related]  

  • 29. Some in vitro susceptibility results with triacetyloleandomycin.
    HORTON GE; DAVIS JW
    Antibiot Chemother (Northfield); 1962 Jun; 12():404-10. PubMed ID: 14449073
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of triacetyloleandomycin in the treatment of pustular and cystic acne: a double blind study.
    MORGINSON WJ; ESKELSON YD
    Antibiot Annu; 1959-1960; 7():657-9. PubMed ID: 14424141
    [No Abstract]   [Full Text] [Related]  

  • 31. Triacetyloleandomycin: further observations on the treatment of acne and pyodermas.
    OLANSKY S; MCCORMICK GE
    Antibiot Annu; 1959-1960; 7():652-6. PubMed ID: 14428587
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of dysentery caused by antibiotic-resistant strains with triacetyloleandomycin (Taocin)].
    TOTANI T; YAMANAKA T; IIDA M; INAMURA Y
    Nihon Densenbyo Gakkai Zasshi; 1962 Jul; 36():139-51. PubMed ID: 13922102
    [No Abstract]   [Full Text] [Related]  

  • 33. Generalized eruption from triacetyloleandomycin.
    WELSH AL; EDE M
    Antibiotic Med Clin Ther (New York); 1960 Mar; 7():179-81. PubMed ID: 13843917
    [No Abstract]   [Full Text] [Related]  

  • 34. The challenge of triacetyloleandomycin in pediatric infections.
    NEWSOME CK
    J Indiana State Med Assoc; 1960 Jun; 53():1131-3. PubMed ID: 14426838
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative studies of erythromycin propionate, erythromycin stearate, and triacetyloleandomycin.
    QUINN EL; COLVILLE JM; COX F
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():103-8. PubMed ID: 14435562
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.
    Kamada AK; Hill MR; Brenner AM; Szefler SJ
    Pharmacotherapy; 1992; 12(2):98-102. PubMed ID: 1570234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [MICROBIOLOGICAL STUDIES ON TRIACETYLOLEANDOMYCIN].
    VAKULENKO NA
    Antibiotiki; 1964 Nov; 9():1017-20. PubMed ID: 14320473
    [No Abstract]   [Full Text] [Related]  

  • 38. Triacetyloleandomycin: a report on its use in a general hospital.
    LEFEBVRE M; BELIVEAU D; DESILETS R; SIMARD J; CHARBONNEAU PE; LAFORTUNE L; ROY J
    Antibiot Annu; 1959-1960; 7():755-60. PubMed ID: 14415263
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid diagnostic susceptibility tests and prompt therapy with triacetyloleandomycin.
    RIPBERGER FM; ANDERSON RH; PALMER RE
    Antibiotic Med Clin Ther (New York); 1959 Nov; 6():662-9. PubMed ID: 14437535
    [No Abstract]   [Full Text] [Related]  

  • 40. A study of triacetyloleandomycin in general infections of institutionalized patients.
    CARTER CH
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():125-8. PubMed ID: 13808017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.